EODData

NASDAQ, DNTH:

06 Oct 25 15:14
LAST:

34.11

CHANGE:
 0.84
OPEN:
35.20
HIGH:
36.39
ASK:
0.00
VOLUME:
330.8K
CHG(%):
2.39
PREV:
34.94
LOW:
33.89
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 Oct 2535.2036.3933.8934.11330.8K
03 Oct 2536.9937.6134.5934.94673.2K
02 Oct 2539.1239.4135.9436.93535.6K
01 Oct 2538.9839.8838.7838.93892.5K
30 Sep 2539.5540.1638.7339.35960.3K
29 Sep 2536.7439.6635.9439.55835.6K
26 Sep 2536.0237.6335.6036.71936K
25 Sep 2536.7337.9635.5035.84524K
24 Sep 2537.9738.3737.1437.19357.6K
23 Sep 2537.8239.0437.5037.87379.4K

COMPANY PROFILE

Name:Dianthus Therapeutics Inc
About:Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases. The company's lead novel and proprietary monoclonal antibody product candidate includes DNTH103, a human monoclonal immunoglobulin G4 with picomolar that binds the active form of C1s, which is in clinical-stage trials for the treatment of generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
Sector:Healthcare
Industry:Biotechnology
Address:7 Times Square, New York, NY, United States, 10036
Website:https://dianthustx.com
CIK:0001690585
ISIN:US2528281080
FIGI:BBG00FB2NPZ0

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

TECHNICAL INDICATORS

MA5:36.85
MA10:37.14
MA20:37.33
MA50:28.41
MA100:23.62
MA200:22.42
RSI14:39.38
WPR14:-100.00
MTM14:-4.78
ROC14:-0.12
ATR:2.28
Week High:40.16
Week Low:33.89
Month High:40.16
Month Low:25.00
Year High:40.16
Year Low:13.37

RECENT SPLITS

Date Ratio
12 Sep 20231-16